Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹300 Cr
P/E Ratio
--
P/B Ratio
-12.85
Industry P/E
37.57
Debt to Equity
-2.77
ROE
0 %
ROCE
-41.69 %
Div. Yield
0 %
Book Value
-6.32
EPS
0.37
CFO
₹-30.01 Cr
EBITDA
₹-38.54 Cr
Net Profit
₹-43.72 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Oxygenta Pharma
| -7.13 | 3.43 | 2.68 | 108.28 | 51.20 | -- | -- |
|
BSE Healthcare
| -4.95 | 1.92 | -0.50 | 24.13 | 20.27 | 23.08 | 9.93 |
|
BSE Small Cap
| -10.08 | 4.17 | -3.87 | 5.97 | 18.98 | 35.50 | 15.85 |
|
2024
|
2023
|
2022
|
2018
|
|
|---|---|---|---|---|
|
Oxygenta Pharma
| 173.34 | 9.91 | 2.53 | 35.00 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | -23.41 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 753.90 | 6,836.12 | 27.42 | 13.8 | |
| 2,202.50 | 9,009.27 | 74.22 | 12.96 | |
| 416.75 | 5,136.09 | 68.88 | 6.24 | |
| 910.95 | 5,226.93 | 41.03 | 14.76 |
No Review & Analysis are available.
S.S. Organics Limited manufactures and sells anti ulcerative and anti-bacterial drugs in India. It is also involved in contract manufacturing work, including cirprofloxacin HCL from Q-acid and cloxacillim sodium. The company was incorporated in 1990... and is based in Hyderabad, India. Read more
Incorporated
1990
Chairman
Sai Sudhakar Vankineni
Managing Director
Sai Sudhakar Vankineni
Headquarters
Sangareddy, Telangana
Website
Looking for more details about Oxygenta Pharmaceutical Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Oxygenta Pharmaceutical Ltd stood at ₹ 73 Cr as on 31-Dec-24
The share price of Oxygenta Pharmaceutical Ltd is ₹81.23 (BSE) as of 24-Apr-2025 IST. Oxygenta Pharmaceutical Ltd has given a return of 51.2% in the last 3 years.
Oxygenta Pharmaceutical Ltd has a market capitalisation of ₹ 300 Cr as on 24-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Oxygenta Pharmaceutical Ltd is -12.85 times as on 24-Apr-2025, a 448% discount to its peers’ median range of 3.69 times.
Since, TTM earnings of Oxygenta Pharmaceutical Ltd is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Oxygenta Pharmaceutical Ltd and enter the required number of quantities and click on buy to purchase the shares of Oxygenta Pharmaceutical Ltd.
S.S. Organics Limited manufactures and sells anti ulcerative and anti-bacterial drugs in India. It is also involved in contract manufacturing work, including cirprofloxacin HCL from Q-acid and cloxacillim sodium. The company was incorporated in 1990 and is based in Hyderabad, India.
The prominent promoters of Oxygenta Pharmaceutical Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
M V S Prasad Reddy |
25.56%
|
|
Sunil Vishram Chawda |
11.25%
|
|
Aakanksha M Chawda |
4.28%
|
The chairman of the company is Sai Sudhakar Vankineni, and the managing director is Sai Sudhakar Vankineni.
There is no promoter pledging in Oxygenta Pharmaceutical Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
9,512
|
|
|
6,653
|
|
|
5,320
|
|
|
5,217
|
| Oxygenta Pharmaceutical Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
--
|
|
Operating margin(%)
|
-16.63
|
|
Net Margin(%)
|
-0.18
|
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of Oxygenta Pharmaceutical Ltd was ₹0 Cr.
₹7.38
(
